These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21772326)

  • 1. Policing Parkin with a UblD.
    Liu F; Walters KJ
    EMBO J; 2011 Jul; 30(14):2757-8. PubMed ID: 21772326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoregulation of Parkin activity through its ubiquitin-like domain.
    Chaugule VK; Burchell L; Barber KR; Sidhu A; Leslie SJ; Shaw GS; Walden H
    EMBO J; 2011 Jun; 30(14):2853-67. PubMed ID: 21694720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkin function in Parkinson's disease.
    Arkinson C; Walden H
    Science; 2018 Apr; 360(6386):267-268. PubMed ID: 29674580
    [No Abstract]   [Full Text] [Related]  

  • 4. A disease state mutation unfolds the parkin ubiquitin-like domain.
    Safadi SS; Shaw GS
    Biochemistry; 2007 Dec; 46(49):14162-9. PubMed ID: 18004887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling.
    Sha D; Chin LS; Li L
    Hum Mol Genet; 2010 Jan; 19(2):352-63. PubMed ID: 19880420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
    Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of parkin in familial and sporadic Parkinson's disease.
    Dawson TM; Dawson VL
    Mov Disord; 2010; 25 Suppl 1(0 1):S32-9. PubMed ID: 20187240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation mechanisms of the E3 ubiquitin ligase parkin.
    Panicker N; Dawson VL; Dawson TM
    Biochem J; 2017 Aug; 474(18):3075-3086. PubMed ID: 28860335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkin: much more than a simple ubiquitin ligase.
    Alves da Costa C; Checler F
    Neurodegener Dis; 2012; 10(1-4):49-51. PubMed ID: 22204976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do Parkin mutations result in neurodegeneration?
    Imai Y; Takahashi R
    Curr Opin Neurobiol; 2004 Jun; 14(3):384-9. PubMed ID: 15194120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.
    Chung KK; Thomas B; Li X; Pletnikova O; Troncoso JC; Marsh L; Dawson VL; Dawson TM
    Science; 2004 May; 304(5675):1328-31. PubMed ID: 15105460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-protein ligase parkin and its role in the development of Parkinson's disease.
    Buneeva OA; Medvedev AE
    Biochemistry (Mosc); 2006 Aug; 71(8):851-60. PubMed ID: 16978147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
    Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.
    Fiesel FC; Caulfield TR; Moussaud-Lamodière EL; Ogaki K; Dourado DF; Flores SC; Ross OA; Springer W
    Hum Mutat; 2015 Aug; 36(8):774-86. PubMed ID: 25939424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
    Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
    Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.
    Avraham E; Rott R; Liani E; Szargel R; Engelender S
    J Biol Chem; 2007 Apr; 282(17):12842-50. PubMed ID: 17327227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on "S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function".
    Lipton SA; Nakamura T; Yao D; Shi ZQ; Uehara T; Gu Z
    Science; 2005 Jun; 308(5730):1870; author reply 1870. PubMed ID: 15976289
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkin suppresses the expression of monoamine oxidases.
    Jiang H; Jiang Q; Liu W; Feng J
    J Biol Chem; 2006 Mar; 281(13):8591-9. PubMed ID: 16455660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine covalently modifies and functionally inactivates parkin.
    LaVoie MJ; Ostaszewski BL; Weihofen A; Schlossmacher MG; Selkoe DJ
    Nat Med; 2005 Nov; 11(11):1214-21. PubMed ID: 16227987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases.
    Ren Y; Jiang H; Ma D; Nakaso K; Feng J
    Hum Mol Genet; 2011 Mar; 20(6):1074-83. PubMed ID: 21177257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.